409 results on '"Tarleton, Rick L."'
Search Results
2. Discovery of an orally active benzoxaborole prodrug effective in the treatment of Chagas disease in non-human primates
3. Serial ‘deep-sampling’ PCR of fragmented DNA reveals the wide range of Trypanosoma cruzi burden among chronically infected hosts and allows accurate monitoring of parasite load following treatment
4. From Questions to Effective Answers: On the Utility of Knowledge-Driven Querying Systems for Life Sciences Data
5. Positive clinical outcome using a modified dosing regimen of benznidazole in dogs at high risk for infection or acutely infected with Trypanosoma cruzi.
6. Protozoan persister-like cells and drug treatment failure
7. cGAS–STING Pathway Activation during Trypanosoma cruzi Infection Leads to Tissue-Dependent Parasite Control
8. DIAGNOSIS AND TREATMENT OF A NATURAL INFECTION WITH TRYPANOSOMA CRUZI (CHAGAS DISEASE) IN A SYMPTOMATIC DE BRAZZA'S MONKEY (CERCOPITHECUS NEGLECTUS) IN ALABAMA
9. Frequency Variation and Dose Modification of Benznidazole Administration for the Treatment of Trypanosoma cruzi Infection in Mice, Dogs, and Nonhuman Primates
10. Frequency variation and dose modification of benznidazole administration for the treatment ofTrypanosoma cruziinfection in mice, dogs and non-human primates
11. Delayed Activation of T Cells at the Site of Infection Facilitates the Establishment of Trypanosoma cruzi in Both Naive and Immune Hosts
12. Chemokine receptor 7 (CCR7)-expression and IFNγ production define vaccine-specific canine T-cell subsets
13. From Questions to Effective Answers: On the Utility of Knowledge-Driven Querying Systems for Life Sciences Data
14. Avoiding Clinical Trial Failures in Neglected Tropical Diseases: The Example of Chagas Disease
15. Prophylactic low-dose, bi-weekly benznidazole treatment fails to prevent Trypanosoma cruzi infection in dogs under intense transmission pressure
16. Ontology-Driven Provenance Management in eScience: An Application in Parasite Research
17. New, Combined, and Reduced Dosing Treatment Protocols Cure Trypanosoma cruzi Infection in Mice
18. Quantitative 3D Imaging of Trypanosoma cruzi-Infected Cells, Dormant Amastigotes, and T Cells in Intact Clarified Organs
19. Avoiding Clinical Trial Failures in Neglected Tropical Diseases: The Example of Chagas Disease.
20. CD8+ T cells in Trypanosoma cruzi infection
21. Transgenic parasites accelerate drug discovery
22. Immunity to Trypanosoma cruzi
23. Engineered trivalent immunogen adjuvanted with a STING agonist confers protection against Trypanosoma cruzi infection
24. Changes in Trypanosoma cruzi –Specific Immune Responses after Treatment: Surrogate Markers of Treatment Efficacy
25. Eliminating Chagas Disease: Challenges and a Roadmap
26. Frequency of Interferon-γ-Producing T Cells Specific for Trypanosoma cruzi Inversely Correlates with Disease Severity in Chronic Human Chagas Disease
27. Trypanoside, anti-tuberculosis, leishmanicidal, and cytotoxic activities of tetrahydrobenzothienopyrimidines
28. CD8 + T cells in Trypanosoma cruzi infection
29. Loss of Suppressor Activity in the Serum of Mice Infected with Trypanosoma cruzi
30. Overview of Parasitic Pathogens
31. Overview of the Parasitic Pathogens
32. Potential new clinical therapies for Chagas disease
33. High variation in immune responses and parasite phenotypes in naturally acquired Trypanosoma cruzi infection in a captive non-human primate breeding colony in Texas, USA
34. ReducedTrypanosoma cruzi-specific humoral response and enhanced T cell immunity after treatment interruption with benznidazole in chronic Chagas disease
35. Additional file 1 of Widespread, focal copy number variations (CNV) and whole chromosome aneuploidies in Trypanosoma cruzi strains revealed by array comparative genomic hybridization
36. Additional file of Widespread, focal copy number variations (CNV) and whole chromosome aneuploidies in Trypanosoma cruzi strains revealed by array comparative genomic hybridization
37. Additional file 2 of Widespread, focal copy number variations (CNV) and whole chromosome aneuploidies in Trypanosoma cruzi strains revealed by array comparative genomic hybridization
38. The challenges of chagas disease-Grim outlook or hope?
39. Immune system recognition of Trypanosoma cruzi
40. Strain-specific genome evolution in Trypanosoma cruzi, the agent of Chagas disease
41. A flexible, pan-species, multi-antigen platform for the detection and monitoring of SARS-CoV-2-specific antibody responses
42. Evidence for the role of vacuolar soluble pyrophosphatase and inorganic polyphosphate in Trypanosoma cruzi persistence
43. Ontology-Driven Provenance Management in eScience: An Application in Parasite Research
44. A modified drug regimen clears active and dormant trypanosomes in mouse models of Chagas disease
45. New Scheme of Intermittent Benznidazole Administration in Patients Chronically Infected with Trypanosoma cruzi: Clinical, Parasitological, and Serological Assessment after Three Years of Follow-Up
46. Cutting Edge: Augmenting Muscle MHC Expression Enhances Systemic Pathogen Control at the Expense of T Cell Exhaustion
47. Strain-specific genome evolution inTrypanosoma cruzi, the agent of Chagas disease
48. Activation of the cGAS-STING pathway during Trypanosoma cruzi infection induces a type I interferon response that promotes parasite growth at the infection site
49. Trypanosoma cruzi modulates the profile of memory CD8+ T cells in chronic Chagasʼ disease patients
50. TcruziDB: an integrated Trypanosoma cruzi genome resource
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.